Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553878-13-000017
Filing Date
2013-06-10
Accepted
2013-06-10 20:15:50
Documents
1
Period of Report
2013-06-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3660
  Complete submission text file 0001553878-13-000017.txt   5087
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELI LITTY & CO LIIY CORPORATE CENTER DC 1093 INDIANAPOLIS IN 46285
Business Address
PAUL STEVEN M (Reporting) CIK: 0001237564 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 13904752